These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 33910869)
1. Clinical Characteristics and Outcome of Pathologic N0 Non-small Cell Lung Cancer Patients With False Positive Mediastinal Lymph Node Metastasis on FDG PET-CT. Kim KY; Park HL; Kang HS; Lee HY; Yoo IR; Lee SH; Yeo CD In Vivo; 2021; 35(3):1829-1836. PubMed ID: 33910869 [TBL] [Abstract][Full Text] [Related]
2. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high. Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432 [TBL] [Abstract][Full Text] [Related]
3. The diagnostic ability of Lee JW; Kim EY; Kim DJ; Lee JH; Kang WJ; Lee JD; Yun M Eur Radiol; 2016 Dec; 26(12):4515-4523. PubMed ID: 26943133 [TBL] [Abstract][Full Text] [Related]
5. Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients. Takamochi K; Yoshida J; Murakami K; Niho S; Ishii G; Nishimura M; Nishiwaki Y; Suzuki K; Nagai K Lung Cancer; 2005 Feb; 47(2):235-42. PubMed ID: 15639722 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer. Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680 [TBL] [Abstract][Full Text] [Related]
7. PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma. Poncelet AJ; Lonneux M; Coche E; Weynand B; Noirhomme P; Eur J Cardiothorac Surg; 2001 Sep; 20(3):468-74; discussion 474-5. PubMed ID: 11509265 [TBL] [Abstract][Full Text] [Related]
8. Comparison of GLUT-1, SGLT-1, and SGLT-2 expression in false-negative and true-positive lymph nodes during the Taira N; Atsumi E; Nakachi S; Takamatsu R; Yohena T; Kawasaki H; Kawabata T; Yoshimi N Lung Cancer; 2018 Sep; 123():30-35. PubMed ID: 30089592 [TBL] [Abstract][Full Text] [Related]
9. Combination of Fluorine-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography (¹⁸F-FDG PET/CT) and Tumor Markers to Diagnose Lymph Node Metastasis in Non-Small Cell Lung Cancer (NSCLC): A Retrospective and Prospective Study. Zhai X; Guo Y; Qian X Med Sci Monit; 2020 Jun; 26():e922675. PubMed ID: 32483109 [TBL] [Abstract][Full Text] [Related]
10. [ Li Y; Zhang Y; Guo Z; Hou P; Lv J; Ke M; Liu S; Li S; Yin W; He J; Wang X Cancer Imaging; 2024 Jun; 24(1):68. PubMed ID: 38831354 [TBL] [Abstract][Full Text] [Related]
11. Lymph node metastasis diagnosis using positron emission tomography with 2-[18F] fluoro-2-deoxy-D-glucose as a tracer and computed tomography in surgical cases of non-small cell lung cancer. Ose N; Sawabata N; Minami M; Inoue M; Shintani Y; Kadota Y; Okumura M Eur J Cardiothorac Surg; 2012 Jul; 42(1):89-92. PubMed ID: 22290887 [TBL] [Abstract][Full Text] [Related]
12. A machine learning tool to improve prediction of mediastinal lymph node metastases in non-small cell lung cancer using routinely obtainable [ Rogasch JMM; Michaels L; Baumgärtner GL; Frost N; Rückert JC; Neudecker J; Ochsenreither S; Gerhold M; Schmidt B; Schneider P; Amthauer H; Furth C; Penzkofer T Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):2140-2151. PubMed ID: 36820890 [TBL] [Abstract][Full Text] [Related]
13. Is Delayed Image of 18F-FDG PET/CT Necessary for Mediastinal Lymph Node Staging in Non-Small Cell Lung Cancer Patients? Lee SW; Kim SJ Clin Nucl Med; 2022 May; 47(5):414-421. PubMed ID: 35234195 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of (18)F-2-deoxy-fluoro-D-glucose positron emission tomography for pN2 lymph nodes in patients with lung cancer. Ozawa Y; Hara M; Sakurai K; Nakagawa M; Tamaki T; Nishio M; Shibamoto Y Acta Radiol; 2010 Mar; 51(2):150-5. PubMed ID: 20092375 [TBL] [Abstract][Full Text] [Related]
15. [Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer]. Hu M; Yu JM; Liu NB; Liu LP; Guo HB; Yang GR; Zhang PL; Xu XQ Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):306-9. PubMed ID: 18788639 [TBL] [Abstract][Full Text] [Related]
16. Preoperative evaluation of mediastinal lymph nodes in non-small cell lung cancer using [ Kang YK; Na KJ; Park J; Kwak N; Lee YS; Choi H; Kim YT Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2409-2419. PubMed ID: 38451308 [TBL] [Abstract][Full Text] [Related]
17. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer. Miyasaka Y; Suzuki K; Takamochi K; Matsunaga T; Oh S Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074 [TBL] [Abstract][Full Text] [Related]
18. Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma? Sivrikoz CM; Ak I; Simsek FS; Döner E; Dündar E Thorac Cardiovasc Surg; 2012 Mar; 60(2):116-21. PubMed ID: 21692019 [TBL] [Abstract][Full Text] [Related]
19. Accuracy of positron emission tomography in mediastinal node assessment in coal workers with lung cancer. Saydam O; Gokce M; Kilicgun A; Tanriverdi O Med Oncol; 2012 Jun; 29(2):589-94. PubMed ID: 21380783 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic Value of Voskuilen CS; Schweitzer D; Jensen JB; Nielsen AM; Joniau S; Muilwijk T; Necchi A; Azizi M; Spiess PE; Briganti A; Bandini M; Goffin K; Bouchelouche K; van Werkhoven E; Shariat SF; Xylinas E; Azawi NH; Ku JH; Foerster B; van Rhijn BWG; Vegt E; Hendricksen K Eur Urol Oncol; 2020 Feb; 3(1):73-79. PubMed ID: 31591037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]